DSM N.V.
amsterdam : DSM

May 07, 2013 02:23 ET

DSM to acquire 19% interest in Andre Pectin (China)

HEERLEN, THE NETHERLANDS--(Marketwired - May 7, 2013) - Royal DSM, the global Life Sciences and Materials Sciences company, announces today that it has signed agreements to acquire a 19% equity interest in Yantai Andre Pectin Co. Ltd. (Andre Pectin), a China based producer of texturing ingredients. In addition, the parties have agreed that DSM has option rights to increase its stake in Andre Pectin to a majority stake at a later stage. The agreements are subject to customary approvals and certain closing conditions, including the approval of the selling party's shareholders. Closing is expected in Q3 2013.

Andre Pectin, headquartered in Yantai (Shandong Province, China), was established in 2003 and is active in the manufacturing and sale of apple and citrus pectin, a key food ingredient providing texture, as well as pectin related health supplements. Andre Pectin realizes annual net sales of around EUR30 million.

DSM - Bright Science. Brighter Living.™

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 23,500 employees deliver annual net sales of around EUR9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.

Press release-pdf:

http://hugin.info/130663/R/1699754/560853.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: DSM N.V. via Thomson Reuters ONE

[HUG#1699754]

Contact Information

  • For more information:
    DSM Corporate Communications
    Herman Betten
    tel. +31 (0) 45 5782017
    e-mail Email Contact

    DSM Investor Relations
    Dave Huizing
    tel. +31 (0) 45 5782864
    e-mail Email Contact